Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−19.83 MUSD
11.79 M
Om Bellerophon Therapeutics, Inc.
Sektor
Bransch
VD
Craig R. Jalbert
Webbplats
Huvudkvarter
Warren
Employees (FY)
18
Grundat
2009
FIGI
BBG007X1TKD5
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
